Appendix 4D and Interim Report
| Stock | Cleanspace Holdings Ltd (CSX.ASX) |
|---|---|
| Release Time | 26 Feb 2026, 8:50 a.m. |
| Price Sensitive | Yes |
CleanSpace reports 10% revenue growth in H1 FY26
- Europe revenue grew 26%, led by West Europe and Nordics
- North America revenue grew 8%, with progress in key sectors
- APAC and ROW revenue declined 22% due to mixed performance
- Investments in sales, marketing, and R&D to support future growth
CleanSpace Holdings Limited reported a positive half-year result, with total revenue increasing by 10% to $10.1 million, reflecting continued momentum in its core industrial PAPR markets and steady progress against its strategic priorities. The company's largest and most established European markets performed particularly well, delivering growth of 26%, while the US business grew 8% amid a volatile economic and regulatory environment. Performance in APAC and Rest of World (ROW) markets was more variable, influenced by tougher prior-year comparisons that included one-off new business wins. Throughout the period, management remained focused on execution, investing prudently to strengthen sales and marketing capability and to accelerate R&D, ensuring the company is well positioned to capture long-term growth opportunities. CleanSpace continued to deliver meaningful innovation during the period, with the latest addition to the product range, CS Work, gaining traction in the market with sales growth of 70% during the half year. The company also successfully relaunched its Bluetooth-enabled SMART App and enhanced Data Insights reporting platform, providing workers with real-time respiratory safety assurance and supporting organisations with actionable safety intelligence. Progress towards the certification of new respirator models is now at an advanced stage in several of CleanSpace's core markets, with launches expected in late FY26 and beyond. These products are anticipated to create additional revenue growth opportunities and further expand the company's addressable market where compliance and performance standards are becoming more stringent.
CleanSpace remains focused on growing its installed base of respirator units, with consumables revenue expected to grow at a moderately faster rate than hardware sales over time, providing a highly profitable and recurring revenue stream that underpins continued margin sustainability. The company's broader Asia expansion strategy continues to evolve, with progress being made alongside partners in Korea, Japan, and Southeast Asia, and sales momentum in the region expected to improve as product certifications are granted and the distribution network matures.